Paper · 1997

Meropenem versus ceftazidime plus amikacin in the treatment of febrile episodes in neutropenic patients: a randomized study.

Rafael de la Cámara, Angela Figuera, Anna Maria Sureda, Gerardo Julio Hermida, G Verge, Ignacio Olalla, J.M. Fernández Rañada, A Domingo-Albós

PubMed, 82(6), 668–675 · Published 1 November 1997

View at the publisherCite this paper

In brief

“Meropenem versus ceftazidime plus amikacin in the treatment of febrile episodes in neutropenic patients: a randomized study.” is a 1997 paper by Rafael de la Cámara and 7 co-authors, published in PubMed. OpenAlex counts 23 citations as of 19 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
23
Most cited in
2024 (2)
Field-weighted impact
0.58
References
23
Authors
8

Abstract

BACKGROUND AND OBJECTIVE: Meropenem is the first of a new class of carbapenems which may be administered without cilastatin. This study was performed to assess the clinical efficacy and tolerability of meropenem monotherapy (1 g/8 h) compared with the standard combination of ceftazidime (2 g/8 h) plus amikacin (15 mg/kg/day) for the empirical treatment of… Read the full abstract at the publisher.

Excerpt. This paper is not open access.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

de la Cámara, R., Figuera, A., Sureda, A. M., Hermida, G. J., Verge, G., Olalla, I., Rañada, J. F., & Domingo-Albós, A. (1997). Meropenem versus ceftazidime plus amikacin in the treatment of febrile episodes in neutropenic patients: a randomized study. PubMed, 82(6), 668–675. https://pubmed.ncbi.nlm.nih.gov/9580087

MLA 9

de la Cámara, Rafael, et al. “Meropenem versus ceftazidime plus amikacin in the treatment of febrile episodes in neutropenic patients: a randomized study.” PubMed, vol. 82, no. 6, 1997, pp. 668–675. https://pubmed.ncbi.nlm.nih.gov/9580087.

Chicago

de la Cámara, Rafael, Angela Figuera, Anna Maria Sureda, Gerardo Julio Hermida, G Verge, Ignacio Olalla, J.M. Fernández Rañada, and A Domingo-Albós. 1997. “Meropenem versus ceftazidime plus amikacin in the treatment of febrile episodes in neutropenic patients: a randomized study.” PubMed 82 (6): 668–675. https://pubmed.ncbi.nlm.nih.gov/9580087.

Harvard

de la Cámara, R. et al. (1997) ‘Meropenem versus ceftazidime plus amikacin in the treatment of febrile episodes in neutropenic patients: a randomized study.’, PubMed, 82(6), pp. 668–675. Available at: https://pubmed.ncbi.nlm.nih.gov/9580087.

IEEE

R. de la Cámara et al., “Meropenem versus ceftazidime plus amikacin in the treatment of febrile episodes in neutropenic patients: a randomized study.,” PubMed, vol. 82, no. 6, pp. 668–675, 1997.

BibTeX

@article{delacamara1997meropenem,
  title     = {{Meropenem versus ceftazidime plus amikacin in the treatment of febrile episodes in neutropenic patients: a randomized study.}},
  author    = {de la Cámara, Rafael and Figuera, Angela and Sureda, Anna Maria and Hermida, Gerardo Julio and Verge, G and Olalla, Ignacio and Rañada, J.M. Fernández and Domingo-Albós, A},
  journal   = {PubMed},
  year      = {1997},
  volume    = {82},
  number    = {6},
  pages     = {668--675},
  url       = {https://pubmed.ncbi.nlm.nih.gov/9580087}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201311
201511
201811
201911
202111
202422
202611

Its field-weighted citation impact is 0.58: it has been cited 0.58 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Oncology › Neutropenia and Cancer Infections

  • meropenem
  • ceftazidime
  • amikacin
  • febrile neutropenia
  • neutropenic cancer patients
  • empirical antibiotic therapy
  • carbapenems
  • bone marrow transplant recipients

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

de la Cámara, R., Figuera, A., Sureda, A. M., Hermida, G. J., Verge, G., Olalla, I., Rañada, J. F., & Domingo-Albós, A. (1997). Meropenem versus ceftazidime plus amikacin in the treatment of febrile episodes in neutropenic patients: a randomized study. PubMed, 82(6), 668–675. https://pubmed.ncbi.nlm.nih.gov/9580087

How many times has this paper been cited?

23 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Rafael de la Cámara, Angela Figuera, Anna Maria Sureda, Gerardo Julio Hermida, G Verge, Ignacio Olalla, J.M. Fernández Rañada, A Domingo-Albós.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.